{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:58:19Z","timestamp":1752983899346,"version":"3.41.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10072-025-08070-5","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:31:36Z","timestamp":1740645096000},"page":"3339-3340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acetylcholine receptor blocking antibodies in myasthenia gravis: reevaluating their role in disease severity and mechanisms"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9938-5355","authenticated-orcid":false,"given":"Hung Youl","family":"Seok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8617-5850","authenticated-orcid":false,"given":"Mi-Yeon","family":"Eun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"8070_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07889-8","author":"F Aguirre","year":"2024","unstructured":"Aguirre F, Justo ME, Cialdella L, Paz ML (2024) AChR-blocking antibodies and complement system dynamics: evaluating their interplay and clinical implications in myasthenia Gravis. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-024-07889-8","journal-title":"Neurol Sci"},{"key":"8070_CR2","doi-asserted-by":"publisher","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia Gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med 10(11). https:\/\/doi.org\/10.3390\/jcm10112235","DOI":"10.3390\/jcm10112235"},{"key":"8070_CR3","doi-asserted-by":"publisher","first-page":"596382","DOI":"10.3389\/fneur.2020.596382","volume":"11","author":"JLS Thomsen","year":"2020","unstructured":"Thomsen JLS, Andersen H (2020) Outcome measures in clinical trials of patients with myasthenia Gravis. Front Neurol 11:596382. https:\/\/doi.org\/10.3389\/fneur.2020.596382","journal-title":"Front Neurol"},{"issue":"12","key":"8070_CR4","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1007\/s10072-024-07577-7","volume":"45","author":"R Mantegazza","year":"2024","unstructured":"Mantegazza R, Sacca F, Antonini G, Bonifati DM, Evoli A, Habetswallner F, Liguori R, Pegoraro E, Rodolico C, Schenone A et al (2024) Therapeutic challenges and unmet needs in the management of myasthenia Gravis: an Italian expert opinion. Neurol Sci 45(12):5671\u20135683. https:\/\/doi.org\/10.1007\/s10072-024-07577-7","journal-title":"Neurol Sci"},{"issue":"10","key":"8070_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/wnl.33.10.1316","volume":"33","author":"UA Besinger","year":"1983","unstructured":"Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A (1983) Myasthenia Gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33(10):1316\u20131321. https:\/\/doi.org\/10.1212\/wnl.33.10.1316","journal-title":"Neurology"},{"issue":"7","key":"8070_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10072-015-2236-8","volume":"36","author":"SY Kang","year":"2015","unstructured":"Kang SY, Oh JH, Song SK, Lee JS, Choi JC, Kang JH (2015) Both binding and blocking antibodies correlate with disease severity in myasthenia Gravis. Neurol Sci 36(7):1167\u20131171. https:\/\/doi.org\/10.1007\/s10072-015-2236-8","journal-title":"Neurol Sci"},{"issue":"11","key":"8070_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","volume":"16","author":"MC Dalakas","year":"2020","unstructured":"Dalakas MC, Alexopoulos H, Spaeth PJ (2020) Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Rev Neurol 16(11):601\u2013617. https:\/\/doi.org\/10.1038\/s41582-020-0400-0","journal-title":"Nat Rev Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08070-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:45:40Z","timestamp":1749530740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["8070"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08070-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}